Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Frontiers in Oncology|August 22, 2022
Inhibitory of active dual cancer targeting 5-Fluorouracil nanoparticles on liver cancer in vitro and in vivoMingrong Cheng, Dejian Dai
Diabetes/Metabolism Research and Reviews|December 10, 2025
Review on the Gut-Kidney Axis Mechanism and Therapeutic Strategies in Diabetic NephropathyQing Li, Mingrong Cheng, Xiaoyan Zhang
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 8, 2026
Non-coding RNA Trojan nanocarriers in CRC: Mechanistic crossroads and therapeutic challengesMingrong Cheng, Yucheng Ni, Wei Zhang, et al.
International Journal of Nanomedicine|June 24, 2026
Reprogramming Metabolism and Immunity: Nanotechnology's Promise for Hepatocellular Carcinoma Precision TherapyMingrong Cheng, Yucheng Ni, Wei Zhang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|October 12, 2018
Synthesis of Biotin-Modified Galactosylated Chitosan Nanoparticles and Their Characteristics in Vitro and in VivoMingrong Cheng, Daxi Ma, Kangkang Zhi, et al.
Oncotarget|September 24, 2017
Anti-cancer efficacy of biotinylated chitosan nanoparticles in liver cancerMingrong Cheng, Weiping Zhu, Qing Li, et al.
Experimental and Therapeutic Medicine|September 26, 2022
Therapeutic effect of autologous bone marrow cells injected into the liver under the guidance of B‑ultrasound in the treatment of HBV‑related decompensated liver cirrhosisLei Li, Yanhui Si, Mingrong Cheng, et al.
International Journal of Molecular Medicine|July 3, 2026
Oral‑gut axis in systemic disease: A barrier‑metabolism‑immunity three‑dimensional regulatory model (Review)Qing Li, Mingrong Cheng, Weiwei Li, et al.
Frontiers in Physiology|January 17, 2022
Autologous Bone Marrow Cell Infusion for the Treatment of Decompensated Liver Cirrhosis Patients With Type 2 Diabetes MellitusBaochi Liu, Mingrong Cheng, Lin Lang, et al.
International Journal of Nanomedicine|February 5, 2014
Optimized synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and their characteristicsMingrong Cheng, Houxiang Chen, Yong Wang, et al.
Pageof 3